Herceptin, the breast cancer combatting drug, has
finally been approved for use in the National Health Service. The treatment has already been available in the US for five years, and some European countries have had it almost as long. The delay in bringing it to the UK has
infuriated many breast cancer patients and their families, as the relief it brings from the disease can be significant.